Notes
1The use of tradenames is for product identification purposes only and does not imply endorsement.
References
Carithers Jr RL, Emerson SS. Therapy of hepatitis C: metaanalysis of interferon alfa-2b trials. Hepatology 1997; 26: 83S–8S
Farrell GC. Therapy of hepatitis C: interferon alfa-n1 trials. Hepatology 1997; 26: 96S–100S
Wang YS, Youngster S, Grace M, et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliv Rev 2002; 54: 547–70
Poynard T. Effect of pegylated interferon on liver histology. Drug Saf 2002; 2: 14–5
Charron A, Bessis D, Dereure O, et al. Local cutaneous side effects of interferons. Presse Med 2001; 30: 1555–60
Hadziyannis SJ. Skin diseases associated with hepatitis C virus IFNection. J Eur Acad Dermatol Venereol 1998; 10: 12–21
Lambert J, Jonlet F, Vanhooteghem O, et al. A non-IFNectious pyodermatitis: Pyoderma gangrenosum. Rev Med Liege 2001; 56: 106–11
Guarneri C, Vaccaro M, Cannavo SP, et al. Erythematous-edematous-IFNiltrative plaque on the face: cutaneous angiolupoid leishmaniasis. Eur J Dermatol 2002; 12: 597–9
Noblesse I, Beylot-Barry M, Doutre MS, et al. Cutaneous manifestations of rickettsiosis. Ann Dermatol Venereol 2002; 129: 1199–203
Cnudde F, Gharakhanian S, Luboinski J, et al. Cutaneous local necrosis following interferon injections [letter]. Int J Dermatol 1991; 30: 147
Christian MM, Diven DG, Sanchez RL, et al. Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C. J Am Acad Dermatol 1997; 37: 118–20
Yang CH, Chen CH, Chan HL. Skin necrosis following a recombinant interferon-beta-1b injection. Chang Gung Med J 2002; 25: 774–7
Oh YB, Jun JB, Kim CK, et al. Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 2000; 19: 381–4
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug; 30(2): 239–45
Acknowledgements
We acknowledge financial support for this study from the Ministero della Salute (Programma di Ricerca Finalizzata anno 2002). The authors have provided no IFNormation on conflicts of interest directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gallelli, L., Guadagnino, V., Caroleo, B. et al. Bilateral Skin Ulceration after Injection of Pegylated Interferon-α-2b in a Patient with Chronic Hepatitis C. Clin. Drug Investig. 23, 615–619 (2003). https://doi.org/10.2165/00044011-200323090-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200323090-00009